kaiser permanente glp-1 coverage news The number of Americans taking a drug for weight loss is on the rise., A new Gallup poll shows 11% of adults say they are currently using one, a dramatic increase from just two years ago, when GLP-1s and Workforce Wellness

The Intervention: Bariatric Surgery Bariatric or metabolic surgery, such as gastric sleeve or gastric bypass, is generally considered the most aggressive, yet also the most effective and durable, treatment for severe obesity

During Open Enrollment Periods, you can ask about changes to drug coverage

This common gastrointestinal side effect occurs in approximately 8-30% of patients taking semaglutide (Ozempic, Wegovy, or Rybelsus) and is most pronounced during initial treatment and dose escalations

But its important to have a clear understanding of the drugs risks before it can be safely prescribed

Appetite reduction often noticed within the first week